BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11022683)

  • 1. [The mechanism of hormone-independent recurrence of prostate cancer].
    Fukabori Y
    Nihon Rinsho; 2000 Jul; 58 Suppl():45-52. PubMed ID: 11022683
    [No Abstract]   [Full Text] [Related]  

  • 2. The androgen receptor and mechanisms for androgen independence in prostate cancer.
    Javidan J; Deitch AD; Shi XB; de Vere White RW
    Cancer Invest; 2005; 23(6):520-8. PubMed ID: 16203660
    [No Abstract]   [Full Text] [Related]  

  • 3. Biology of castration-recurrent prostate cancer.
    Azzouni F; Mohler J
    Urol Clin North Am; 2012 Nov; 39(4):435-52. PubMed ID: 23084522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostate cancer and androgen].
    Komiya A; Ito H
    Nihon Rinsho; 2000 Jul; 58 Suppl():35-40. PubMed ID: 11022681
    [No Abstract]   [Full Text] [Related]  

  • 5. Signal transduction in prostate cancer progression.
    Gioeli D
    Clin Sci (Lond); 2005 Apr; 108(4):293-308. PubMed ID: 15603554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of androgen receptor signaling in prostate cancer.
    Dehm SM; Tindall DJ
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):63-74. PubMed ID: 15757439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development and progression of prostate cancer in relation with androgen dependency].
    Shimazaki J
    Nihon Rinsho; 1998 Aug; 56(8):1953-8. PubMed ID: 9750486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the androgen receptor in the development and progression of prostate cancer.
    Jenster G
    Semin Oncol; 1999 Aug; 26(4):407-21. PubMed ID: 10482183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone dependency of prostate cancer].
    Suzuki H; Ito H
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():59-64. PubMed ID: 12599546
    [No Abstract]   [Full Text] [Related]  

  • 10. Human prostate cancer (PC-82) in nude mice: a model to study androgen regulated tumor growth.
    van Steenbrugge GJ; Groen M; Bolt-de Vries J; Romijn JC; Schroeder FH
    Prog Clin Biol Res; 1985; 185A():23-50. PubMed ID: 4034577
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical and biological study of androgen independent prostate cancer (AI PCa).
    Logothetis CJ; Hoosein NM; Hsieh JT
    Semin Oncol; 1994 Oct; 21(5):620-9. PubMed ID: 7524155
    [No Abstract]   [Full Text] [Related]  

  • 12. Androgen receptor and prostate cancer: molecular aspects and gene expression profiling.
    Sommer A; Haendler B
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):702-11. PubMed ID: 14579520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms underlying the development of androgen-independent prostate cancer.
    Pienta KJ; Bradley D
    Clin Cancer Res; 2006 Mar; 12(6):1665-71. PubMed ID: 16551847
    [No Abstract]   [Full Text] [Related]  

  • 14. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.
    Agoulnik IU; Vaid A; Nakka M; Alvarado M; Bingman WE; Erdem H; Frolov A; Smith CL; Ayala GE; Ittmann MM; Weigel NL
    Cancer Res; 2006 Nov; 66(21):10594-602. PubMed ID: 17079484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of prostate cancer recurrence].
    Mizokami A; Namiki M
    Hinyokika Kiyo; 2002 Nov; 48(11):709-11. PubMed ID: 12512146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms.
    Schröder FH
    Eur Urol; 2008 Jun; 53(6):1129-37. PubMed ID: 18262723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Androgens and androgen receptor in prostate cancer].
    Miyoshi Y; Kubota Y
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():489-93. PubMed ID: 16689355
    [No Abstract]   [Full Text] [Related]  

  • 18. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.
    Kikugawa T; Kinugasa Y; Shiraishi K; Nanba D; Nakashiro K; Tanji N; Yokoyama M; Higashiyama S
    Prostate; 2006 Jul; 66(10):1092-9. PubMed ID: 16637071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiologic and endocrine aspects.
    Sica G
    J Int Med Res; 1990; 18 Suppl 1():8-10. PubMed ID: 2323486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor action in hormone-dependent and recurrent prostate cancer.
    Agoulnik IU; Weigel NL
    J Cell Biochem; 2006 Oct; 99(2):362-72. PubMed ID: 16619264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.